PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: A novel role for PD98059

Journal of Endocrinology

Volumn 198, Issue 1, 2008, Pages 243-252

  Al Shanti, Nasser ^a   Stewart, Claire E ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CREATINE KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOD PROTEIN; MYOGENIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE EXPRESSION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CREATINE KINASE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; INSULIN-LIKE GROWTH FACTOR I; MICE; MYOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS;

EID: 47849084602     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0151     Document Type: Article

References (51)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT & Saltiel AR 1995 PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. Journal of Biological Chemistry 270 27489-27494.
2. Andres V & Walsh K 1996 Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. Journal of Cell Biology 132 657-666.
3. Arnold HH & Winter B 1998 Muscle differentiation: more complexity to the network of myogenic regulators. Current Opinion in Genetics and Development 8 539-544.
4. Atherton GT, Travers H, Deed R & Norton JD 1996 Regulation of cell differentiation in C2C12 myoblasts by the Id3 helix-loop-helix protein. Cell Growth and Differentiation 7 1059-1066.
5. Bergstrom DA, Penn BH, Strand A, Perry RL, Rudnicki MA & Tapscott SJ 2002 Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Molecular Cell 9 587-600.
6. Buckingham M 1992 Making muscle in mammals. Trends in Genetics 8 144-148.
7. Cobb LJ, Salih DA, Gonzalez I, Tripathi G, Carter EJ, Lovett F, Holding C & Pell JM 2004 Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. Journal of Cell Science 117 1737-1746.
8. Coolican SA, Samuel DS, Ewton DZ, McWade FJ & Florini JR 1997 The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. Journal of Biological Chemistry 272 6653-6662.
9. Davies SP, Reddy H, Caivano M & Cohen P 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal 351 95-105.
10. Edmondson DG & Olson EN 1993 Hehx-loop-helix proteins as regulators of muscle-specific transcription. Journal of Biological Chemistry 268 755-758.
11. Ewton DZ, Roof SL, Magri KA, McWade FJ & Florini JR 1994 IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. Journal of Cellular Physiology 161 277-284.
12. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F et al. 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase. Journal of Biological Chemistry 273 18623-18632.
13. Florini JR, Ewton DZ & Coolican, SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine Reviews 17 481-517.
14. Foulstone EJ, Meadows KA, Holly JM & Stewart CE 2001 Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. Journal of Cellular Physiology 189 207-215.
15. Galvin CD, Hardiman O & Nolan CM 2003 IGF-1 receptor mediates differentiation of primary cultures of mouse skeletal myoblasts. Molecular and Cellular Endocrinology 200 19-29.
16. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D & Lassar AB 1995 Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267 1018-1021.
17. Hoshino R, Tanimura S, Watanabe K, Kataoka T & Kohno M 2001 Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1). Journal of Biological Chemistry 276 2686-2692.
18. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N & Nakayama K 2002 U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. Journal of Biological Chemistry 277 47366-47372.
19. Isobe A, Hirayama E & Kim J 1998 Characterization of myogenin expression in myotubes derived from quail myoblasts transformed with a temperature sensitive mutant of Rous sarcoma virus. Cell Structure and Function 23 57-67.
20. James PL, Jones SB, Busby WH Jr, Clemmons DR & Rotwein P 1993 A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. Journal of Biological Chemistry 268 22305-22312.
21. Johnson GL & Lapadat R 2002 Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 1911-1912.
22. Koyama M, Matsuzaki Y, Yogosawa S, Hitomi T, Kawanaka M & Sakai T 2007 ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Molecular Cancer Therapeutics 6 1579-1587.
23. Krutzik PO & Nolan GP 2003 Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry. Part A 55 61-70.
24. Kultz D, Madhany S & Burg MB 1998 Hyperosmolality causes growth arrest of murine kidney cells. Induction of GADD45 and GADD153 by osmosensing via stress-activated protein kinase 2. Journal of Biological Chemistry 273 13645-13651.
25. Lee SE, Woo KM, Kim, SY, Kim HM, Kwack K, Lee ZH & Kim HH 2002 The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30 71-77.
26. Matsumoto M, Sudo T, Saito T, Osada H & Tsujimoto M 2000 Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclasto-genesis mediated by receptor activator of NF-kappa B ligand (RANKL). Journal of Biological Chemistry 273 31155-31161.
27. Meadows KA, Holly JM & Stewart CE 2000 Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. Journal of Cellular Physiology 183 330-337.
28. Melnikova IN & Christy BA 1996 Muscle cell differentiation is inhibited by the helix-loop-helix protein Id3. Cell Growth and Differentiation 7 1067-1079.
29. Miller KJ, Thaloor D, Matteson S & Pavlath GK 2000 Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. American Journal of Physiology. Cell Physiology 278 C174-C181.
30. Molkentin JD & Olson EN 1996 Defining the regulatory networks for muscle development. Current Opinion in Genetics and Development 6 445-453.
31. Moon DO, Park C, Heo MS, Park YM, Choi YH & Kim GY 2007 PD98059 triggers G1 arrest and apoptosis in human leukemic U937 cells through downregulation of Akt signal pathway. International Immunopharmacology 7 36-45.
32. Navarro M, Valentinis B, Belletti B, Romano G, Reiss K & Baserga R 2001 Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1. Endocrinology 142 5149-5157.
33. Radonic A, Thulke S, Mackay IM, Landt O, Siegert W & Nitsche A 2004 Guideline to reference gene selection for quantitative real-time PCR. Biochemical and Biophysical Research Communications 313 856-862.
34. Rawls A & Olson EN 1997 MyoD meets its maker. Cell 89 5-8.
35. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD & Glass DJ 1999 Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286 1738-1741.
36. Rosenthal SM, Brunetti A, Brown EJ, Mamula PW & Goldfine ID 1991 Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. Journal of Clinical Investigation 87 1212-1219.
37. Sarbassov DD, Stefanova R, Grigoriev VG & Peterson CA 1995 Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in the NFB4 mutant muscle cell line. PNAS 92 10874-10878.
38. de la Serna IL, Roy K, Carlson KA & Imbalzano AN 2001 MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes. Journal of Biological Chemistry 276 41486-41491.
39. Singleton JR & Feldman EL 2001 Insulin-like growth factor-I in muscle metabolism and myotherapies. Neurobiology of Disease 8 541-554.
40. Stewart CE & Rotwein P 1996 Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. Journal of Biological Chemistry 271 11330-11338.
41. Stewart CE, Newcomb PV & Holly JM 2004 Multifaceted roles of TNF-α in myoblast destruction: a multitude of signal transduction pathways. Journal of Cellular Physiology 198 237-247.
42. Tollefsen SE, Sadow JL & Rotwein P 1989 Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. PNAS 86 1543-1547.
43. Venuti JM & Cserjesi P 1996 Molecular embryology of skelecal myogenesis. Current Topics in Developmental Biology 34 169-206.
44. Wei S, Wang MW, Teitelbaum SL & Ross FP 2002 Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling. Journal of Biological Chemistry 277 6622-6630.
45. Weintraub H 1993 The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75 1241-1244.
46. Wu J & Lim RW 2005 Regulation of inhibitor of differentiation gene 3 (Id3) expression by Sp2-motif binding factor in myogenic C2C12 cells: downregulation of DNA binding activity following skeletal muscle differentiation. Biochimica et Biophysica Acta 1731 13-22.
47. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY & Puri PL 2000 p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Molecular and Cellular Biology 20 3951-3964.
48. Yaffe D & Saxel O 1977 Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270 725-727.
49. Yamaguchi K, Tomita H, Sugano E, Nakazawa T & Tamai M 2002 Mitogen-activated protein kinase inhibitor, PD98059, inhibits rat retinal pigment epithelial cell replication by cell cycle arrest. Japanese Journal of Ophthalmology 46 634-639.
50. Zheng SM, Jiang MD, Zeng WZ, Xu H, Wang YX, Ma HD, Xie FW, Zhang Y, Qin JP & Wu XL 2007 Effects of extracellular signal-regulated kinase on rat cultured hepatic stellate cells stimulated by acetaldehyde. Journal of Digestive Diseases 8 148-153.
51. Zhu W, Boachie-Adjei O, Rawlins BA, Frenkel B, Boskey AL, Ivashkiv LB & Blobel CP 2007 A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. Journal of Biological Chemistry 282 18676-18685.